Request Deal Involvement

TPG Life Sciences Innovations led a $120m Series A round in Ouro Medicines.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

FGS Global

pr advisors

FGS Global

or

Principals

GSK PLC

bidder

GSK PLC

UPMC ENTERPRISES

bidder

UPMC ENTERPRISES

OURO MEDICINES

target

OURO MEDICINES

TPG LIFE SCIENCES INNOVATION

bidder

TPG LIFE SCIENCES INNOVATION

NORWEST VENTURE PARTNERS

bidder

NORWEST VENTURE PARTNERS

BOYU CAPITAL

bidder

BOYU CAPITAL

NEW ENTERPRISE ASSOCIATES (NEA)

bidder

NEW ENTERPRISE ASSOCIATES (NEA)

MONOGRAPH CAPITAL

bidder

MONOGRAPH CAPITAL

LONG RIVER INVESTMENTS

bidder

LONG RIVER INVESTMENTS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - TPG Life Sciences Innovations led a $120m Series A round in Ouro Medicines.